Human TGF-alpha antiserum (Rabbit) | PAL1

Description Human epidermal development factor (EGF) antiserum was ready by vaccinating hares with human EGF formed to ovalbumin. It cross-responds 100 percent with human EGF and 56% with L-EGF. Crossreactivity to human TGF-α is < 0.01%. This antiserum can be utilized to foster resistant-based measures furthermore, discovery frameworks for human EGF. Reference: Xian CJ et … Read more